tirzepatide vs semaglutide weight loss efficacy vs. for Obesity Semaglutide vs Tirzepatide- Start your

Semaglutide is a groundbreaking medication initially developed as a treatment for Type 2 diabetes

Seven Phase 3 trials are expected to complete through 2026, with potential FDA submission and approval in 2027 or later

The treatment approaches are completely different, so getting the right diagnosis matters

And, fiber can be particularly helpful for people taking semaglutide, considering its impacts on blood sugar and appetite

Thyroid Function Monitoring For patients established on levothyroxine, thyroid function tests (TSH and free T4) should be monitored according to standard protocols: Every 612 months once stable on an established dose 68 weeks after any dose adjustment 68 weeks after starting or changing the dose of Saxenda After significant weight loss or gain More frequently if symptoms of hypo- or hyperthyroidism develop Patients should report symptoms suggesting inadequate thyroid replacement (fatigue, cold intolerance, weight gain, constipation) or excessive replacement (palpitations, tremor, anxiety, heat intolerance, unintentional weight loss)